Nextech V Oncology S.C.S., SICAV-SIF — Form D
Nextech V Oncology S.C.S., SICAV-SIF of LUXEMBOURG-FINDEL, N4, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-09-20. The offering totals $350.0M, of which $46.7M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-09-20
- Form: D
- Accession: 0001712922-17-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Total offering: $350.0M
- Amount sold: $46.7M
- Remaining: $303.3M
- Minimum investment: $1.0M
- Investors: 5
- Date of first sale: 2017-09-12
- Security types: fund interests
- SEC file number: 021-295084
Issuer
- Name: Nextech V Oncology S.C.S., SICAV-SIF
- CIK: 0001712922
- Entity type: Limited Partnership
- Jurisdiction: LUXEMBOURG
- Incorporated: 2017
- Address: 7, RUE LOU HEMMER, LUXEMBOURG-FINDEL, N4, L-1748
- Phone: 352-246-160-6000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| THOMAS LIPS | Executive Officer | ZURICH, V8 |
| N/A NEXTECH V GP S.a.r.l. | Executive Officer | LUXEMBOURG-FINDEL, N4 |
| James Pledger | Executive Officer | Luxembourg, N4 |
| James Vella-Bamber | Executive Officer | Senningerberg, N4 |
| N/A NEXTECH INVEST AG | Promoter | LUXEMBOURG-FINDEL, N4 |
More